Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

11,819 public trials 2,513 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT04606914

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • University of Alabama at Birmingham Womens & Infants Center Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Minnesota - Masonic Cancer Center Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

NCT05691465

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 13 locations
View Trial Details
Recruiting

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

NCT05804370

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Luminis Health Anne Arundel Medical Center Annapolis, Maryland, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

NCT07570979

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Hirakata, Osaka, Japan
View Trial Details
Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

NCT06592924

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 395 locations
View Trial Details
Recruiting

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT07665515

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital Cambridge, United Kingdom
  • The University of Edinburgh - Western General Hospital - Edinburgh Cancer Research Centre Edinburgh, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • St. James's University Hospital Leeds, United Kingdom
View Trial Details

Related conditions